i factor peptide enhanced bone graft P-15L is a safe and effective alternative to local autologous bone graft - I factor bone graftmade of i-FACTOR marginally reduced costs The Revolutionary i-FACTOR Peptide Enhanced Bone Graft: Advancing Spinal Fusion

MagnetOsbone graft The field of spinal surgery has seen significant advancements, with innovations aimed at improving fusion rates, reducing complications, and enhancing patient outcomes. Among these, the i-FACTOR peptide enhanced bone graft has emerged as a pioneering solution, offering a unique approach to spinal fusion2024年9月24日—i-FACTOR is now approved for single-level anterior cervical discectomy fusion(ACDF) with an allograft bone ring, or in conjunction with a PEEK, titanium alloy .... This article delves into the intricacies of this advanced bone graft, exploring its composition, mechanism of action, clinical efficacy, and regulatory standing, providing a comprehensive overview for healthcare professionals and informed patients.

At its core, the i-FACTOR peptide enhanced bone graft is distinguished by its proprietary P-15 Osteogenic Cell Binding Peptide. This peptide is not merely a component; it is the driving force behind the graft's ability to mimic natural bone healing processes.i-FACTOR is the first spinal bone graft powered by P-15 Osteogenic Cell Binding Peptide, and the only bone graft FDA approved for single-level anterior ... The P-15 Peptide is a synthetically produced 15-amino acid sequence, a biomimetic of the cell-binding domain found in type-1 collagen. This sequence is chemically bound to an organic bone mineral (ABM) particle, creating a composite material that actively recruits and binds osteogenic cells. This process is crucial for initiating and accelerating bone formation. Unlike traditional bone graft materials, the i-FACTOR acts as more than just a scaffold; it is designed to actively participate in the biological cascade of bone regeneration.P128. Six-year follow-up of i-FACTOR® peptide enhanced ...

The mechanism of action for the i-FACTOR peptide enhanced bone graft centers on its osteoconductive properties, enhanced by the osteogenic peptide.作者：C Abjornson·2018·被引用次数：28—I-FACTOR is a composite bone graftconsisting of the synthetic P-15 peptide (biomimetic of the type I collagen peptide) absorbed onto ABM. ( ... Once implanted, the P-15 Peptide acts as a potent cell attachment factor, guiding mesenchymal stem cells and osteoprogenitor cells to the graft siteFDA Expands Indications for iFactor Use in Spine Surgery. These cells then differentiate into osteoblasts, which are responsible for synthesizing new bone matrix. This targeted cellular recruitment and differentiation leads to a more robust and predictable fusion process. The i-FACTOR is a composite bone graft, meaning it combines synthetic and biological elements to optimize its performance. This innovative composition has led to its designation as a Class III FDA approved bone graft, underscoring its advanced nature and the rigorous evaluation it has undergone.

Clinical studies and real-world data have consistently demonstrated the efficacy of the i-FACTOR peptide enhanced bone graft. A significant aspect of its validation comes from long-term follow-up studies, such as the six-year follow-up of a randomized controlled trial. These studies have shown that i-FACTOR met all 4 FDA-mandated noninferiority success criteria, proving its safety and effectiveness in single-level anterior cervical discectomy and fusion (ACDF) proceduresi-FACTOR™ Bone Graft - Dean Health Plan. Furthermore, research indicates that i-FACTOR is a safe and effective alternative to local autologous bone graft in certain spinal procedures, such as instrumented TLIFPlatelet-Rich Fibrin as a Bone Graft Material in Oral and Maxillofacial .... The graft is indicated for use in skeletally mature patients for the reconstruction of degenerated cervical discs at one level, typically from C3 to C7.

The economic implications of adopting advanced surgical materials are also a critical consideration. Studies on the cost-effectiveness of peptide enhanced bone graft have yielded promising results.i-FACTOR Putty, with P-15 Osteogenic Cell-Binding Peptide One such analysis concluded that the i-FACTOR is not only cost-effective compared to autograft in ACDF surgery but is the dominant economic strategy.Infuse Bone Graftstimulates the growth of bone-forming cells, manufacturing new bone to replace or heal existing bone. Further research has indicated that i-FACTOR reduced costs within the first year by 1(PDF) Cost-Effectiveness of Peptide Enhanced Bone Graft i ....4% to 2.1%, with savings proving to be incremental over time. This suggests that while the initial investment may be a factor, the long-term benefits in terms of reduced complications and improved outcomes can lead to significant cost savings for healthcare systems.

The regulatory landscape surrounding bone grafts is stringent, and the i-FACTOR peptide enhanced bone graft has navigated these requirements successfully.i-FACTOR® Peptide Enhanced Bone Graftis the only biologic bone graft in orthopedics that incorporates. P-15 osteogenic cell binding peptide to stimulate the ... It is explicitly stated that i-FACTOR should only be used by doctors who are trained in using it and have experience performing cervical spine fusion. This highlights the importance of specialized training and expertise when utilizing such advanced materials. The i-FACTOR is now approved for single-level anterior cervical discectomy fusion (ACDF), often in conjunction with an allograft bone ring or with implants such as PEEK or titanium alloycerapedics: 700-025. This versatility in application further solidifies its role in modern spinal surgery.

While i-FACTOR is a prominent example, the broader category of peptide enhanced bone graft materials is evolving. Other products, such as PearlMatrixBone Graft and ViviGenbone graft, also aim to enhance bone healing through different mechanismsi-FACTOR is the first spinal bone graft powered by P-15 Osteogenic Cell Binding Peptide, and the only bone graft FDA approved for single-level anterior .... Similarly, OsteoAMP is an allogeneic bone graft substitute that utilizes proprietary processing to preserve bone morphogenetic proteins (BMPs) and other growth factors to stimulate the growth of bone-forming cells. These advancements collectively contribute to the growing armamentarium available to spinal surgeons.

In conclusion, the i-FACTOR peptide enhanced bone graft, powered by its unique P-15 Peptide, represents a significant leap forward in spinal fusion technology. Its ability to actively recruit cells, coupled with robust clinical evidence and favorable cost-effectiveness, positions it as a valuable tool for surgeons aiming to achieve optimal fusion outcomes. The ongoing development and refinement of such peptide enhanced bone graft solutions underscore a commitment to improving patient care and advancing the science of orthopedic and spinal surgery作者：ACY Loenen·2021·被引用次数：11—i-FACTOR consists of synthetically produced 15-amino acid long polypeptides(P-15) chemically bound to anorganic bone mineral (ABM) particles, embedded in a ....